Edition:
India

Kala Pharmaceuticals Inc (KALA.OQ)

KALA.OQ on NASDAQ Stock Exchange Global Select Market

12.46USD
1:30am IST
Change (% chg)

$0.12 (+0.97%)
Prev Close
$12.34
Open
$12.32
Day's High
$12.65
Day's Low
$12.32
Volume
24,793
Avg. Vol
48,454
52-wk High
$26.74
52-wk Low
$11.81

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.460
FY 2017 Dec '17 0.00 -1.606
Sep '17 0.00 -0.564
Jun '17 0.00 -0.472
Mar '17 0.00 -0.419
FY 2016 Dec '16 0.00 -0.361
Sep '16 0.00 -0.415
Jun '16 0.00 -0.423
Mar '16 0.00 -0.226
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 3 0.00 0.00 0.00 --
Quarter Ending Dec-18 3 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.00 0.00 0.00 --
Year Ending Dec-19 4 19.85 25.00 14.00 --
Earnings (per share)
Quarter Ending Sep-18 3 -0.53 -0.49 -0.59 --
Quarter Ending Dec-18 3 -0.56 -0.49 -0.65 --
Year Ending Dec-18 3 -2.06 -1.91 -2.25 --
Year Ending Dec-19 4 -2.83 -1.95 -3.38 --
LT Growth Rate (%) 1 -82.80 -82.80 -82.80 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -100.00 -- --
EPS (TTM) % -98.82 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Kala Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -11.02 -14.09 45 --
13 Week -- -- -- --
26 Week -- -- -- --
52 Week -- -- -- --
YTD -- -- -- --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 91.91%
# of Holders: 109
Total Shares Held: 22,576,233
3 Mo. Net Change: 39,232
# New Positions: 3
# Closed Positions: 0
# Increased Positions: 4
# Reduced Positions: 3
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.